The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort
Open accessAbstract
BACKGROUND AND OBJECTIVES: Steroid-resistant nephrotic syndrome is a rare kidney disease involving either immune-mediated or genetic alterations of podocyte structure and function. The rare nature, heterogeneity, and slow evolution of the disorder are major obstacles to systematic genotype-phenotype, intervention, and outcome studies, hampering the development of evidence-based diagnostic and therapeutic concepts. To overcome these limitations, the PodoNet Consortium has created an international registry for congenital nephrotic syndrome and childhood-onset steroid-resistant nephrotic syndrome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Since August of 2009, clinical, biochemical, genetic, and histopathologic information was collected both retrospectively and prospectively from 1655 patients with childhood-onset steroid-resistant nephrotic syndrome, congenital nephrotic syndrome, or persistent subnephrotic proteinuria of likely genetic origin at 67 centers in 21 countries through an online portal. RESULTS: Steroid-resistant nephrotic syndrome manifested in the first 5 years of life in 64% of the patients. Congenital nephrotic syndrome accounted for 6% of all patients. Extrarenal abnormalities were reported in 17% of patients. The most common histopathologic diagnoses were FSGS (56%), minimal change nephropathy (21%), and mesangioproliferative GN (12%). Mutation screening was performed in 1174 patients, and a genetic disease cause was identified in 23.6% of the screened patients. Among 14 genes with reported mutations, abnormalities in NPHS2 (n=138), WT1 (n=48), and NPHS1 (n=41) were most commonly identified. The proportion of patients with a genetic disease cause decreased with increasing manifestation age: from 66% in congenital nephrotic syndrome to 15%-16% in schoolchildren and adolescents. Among various intensified immunosuppressive therapy protocols, calcineurin inhibitors and rituximab yielded consistently high response rates, with 40%-45% of patients achieving complete remission. Confirmation of a genetic diagnosis but not the histopathologic disease type was strongly predictive of intensified immunosuppressive therapy responsiveness. Post-transplant disease recurrence was noted in 25.8% of patients without compared with 4.5% (n=4) of patients with a genetic diagnosis. CONCLUSIONS: The PodoNet cohort may serve as a source of reference for future clinical and genetic research in this rare but significant kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
Lombel, R. M., Gipson, D. S., & Hodson, E. M. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2310-x · Cited by 277
MYO1E Mutations and Childhood Familial Focal Segmental Glomerulosclerosis
Mele, C., Iatropoulos, P., Donadelli, R., Calabria, A., Maranta, R., Cassis, P., Buelli, S., Tomasoni, S., Piras, R., Krendel, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101273 · Cited by 252
Self-citationHigh incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood
Srivastava, T., Simon, S. D., & Alon, U. S. (1999) · Pediatric Nephrology · doi:10.1007/s004670050555 · Cited by 191
Immunosuppression and Renal Outcome in Congenital and Pediatric Steroid-Resistant Nephrotic Syndrome
Büscher, A. K., Kranz, B., Büscher, R., Hildebrandt, F., Dworniczak, B., Pennekamp, P., Kuwertz-Bröking, E., Wingen, A.-M., John, U., Kemper, M., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01190210 · Cited by 181
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Hodson, E. M., Wong, S., Willis, N. S., & Craig, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003594.pub5 · Cited by 149
Disruption of PTPRO Causes Childhood-Onset Nephrotic Syndrome
Özaltın, F., Ibsirlioglu, T., Taşkıran, E. Z., Baydar, D. E., Kaymaz, F. F., Büyükçelik, M., Kılıç, B. D., Balat, A., Iatropoulos, P., Aşan, E., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.026 · Cited by 122
Self-citationGenetic screening in adolescents with steroid-resistant nephrotic syndrome
Lipska-Ziętkiewicz, B. S., Iatropoulos, P., Maranta, R., Caridi, G., Özaltın, F., Anarat, A., Balat, A., Gellermann, J., Trautmann, A., Erdoğan, Ö., et al. (2013) · Kidney International · doi:10.1038/ki.2013.93 · Cited by 93
Self-citationNew developments in steroid-resistant nephrotic syndrome
Saleem, M. A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2239-0 · Cited by 53
Cited by
Romagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Self-citationIdiopathic nephrotic syndrome in children
Noone, D. G., Iijima, K., & Parekh, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30536-1 · Cited by 586
Focal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
on behalf of the International Pediatric Nephrology Association, Trautmann, A., Vivarelli, M., Samuel, S., Gipson, D., Sinha, A., Schaefer, F., Hui, N. K., Boyer, O., Saleem, M. A., et al. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04519-1 · Cited by 389
Self-citationExploring the genetic basis of early-onset chronic kidney disease
Vivante, A., & Hildebrandt, F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.205 · Cited by 344
Metadata
- Authors
- Trautmann, A., Bodria, M., Ozaltin, F., Gheisari, A., Melk, A., Azocar, M., Anarat, A., Caliskan, S., Emma, F., Gellermann, J., Oh, J., Baskin, E., Ksiazek, J., Remuzzi, G., Erdogan, O., Akman, S., Dusek, J., Davitaia, T., Özkaya, O., Papachristou, F., Firszt-Adamczyk, A., Urasinski, T., Testa, S., Krmar, R. T., Hyla-Klekot, L., Pasini, A., Özcakar, Z. B., Sallay, P., Cakar, N., Galanti, M., Terzic, J., Aoun, B., Caldas Afonso, A., Szymanik-Grzelak, H., Lipska, B. S., Schnaidt, S., & Schaefer, F.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2015-04
- Volume
- 10
- Issue
- 4
- Pages
- 592-600
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2098823303
- Cited by
- 283
- References
- 11
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort. https://app.cochat.ai/papers/10.2215/cjn.06260614
- The paper
- Trautmann, A., Bodria, M., Ozaltin, F., Gheisari, A., Melk, A., Azocar, M., Anarat, A., Caliskan, S., Emma, F., Gellermann, J., Oh, J., Baskin, E., Ksiazek, J., Remuzzi, G., Erdogan, O., Akman, S., Dusek, J., Davitaia, T., Özkaya, O., . . . Schaefer, F. (2015). Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.06260614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.